Vicarious Surgical (NYSE:RBOT) Given New $8.50 Price Target at Piper Sandler

Vicarious Surgical (NYSE:RBOT) had its price objective cut by Piper Sandler from $10.50 to $8.50 in a report released on Tuesday,Benzinga reports. They currently have a neutral rating on the stock.

Vicarious Surgical Stock Down 14.9 %

Shares of RBOT stock opened at $8.20 on Tuesday. The firm has a market capitalization of $48.42 million, a P/E ratio of -0.80 and a beta of 1.35. Vicarious Surgical has a twelve month low of $4.27 and a twelve month high of $19.00. The stock’s fifty day simple moving average is $12.56 and its 200 day simple moving average is $10.60.

Vicarious Surgical (NYSE:RBOT) last issued its quarterly earnings data on Monday, March 17th. The company reported ($2.43) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.69) by $0.26. The firm had revenue of $2.09 million for the quarter. During the same quarter in the prior year, the company earned ($2.25) EPS. As a group, equities research analysts expect that Vicarious Surgical will post -10.89 EPS for the current fiscal year.

Institutional Investors Weigh In On Vicarious Surgical

A number of institutional investors have recently made changes to their positions in the stock. Renaissance Technologies LLC grew its position in shares of Vicarious Surgical by 11.6% in the 4th quarter. Renaissance Technologies LLC now owns 11,534 shares of the company’s stock valued at $152,000 after buying an additional 1,200 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Vicarious Surgical by 8.2% in the 4th quarter. Geode Capital Management LLC now owns 30,799 shares of the company’s stock valued at $405,000 after buying an additional 2,336 shares during the last quarter. Finally, DnB Asset Management AS grew its position in shares of Vicarious Surgical by 21.1% in the 4th quarter. DnB Asset Management AS now owns 21,213 shares of the company’s stock valued at $279,000 after buying an additional 3,692 shares during the last quarter. Institutional investors own 47.27% of the company’s stock.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.